Migration notice:
On August 9th, 2025, Finsight.com market data will be renamed and migrated to CreditFlow, a more intuitive, comprehensive and accessible market data platform for all credit products.
Contact us
for more information.
Market Data
Pricing
Solutions
Log In
Market Overview
Health Care
Pharmaceuticals
Parent Companies
Amneal Pharmaceuticals LLC
Amneal Pharmaceuticals LLC
2025-1
Amneal Pharmaceuticals LLC (AMRX) 2025-1
C/P
Sector
Status
Deal Name
Parent
Leads
Region
Date
HYC
HLTH
PRCD
AMRX 2025-1 (USD 2,100m)
Amneal Pharmaceuticals LLC
JPM
USOA
Jul 24, 2025
CCY
SIZE (M)
TNR
MTY
RNK
MO
SP
FI
TYPE
BNCH
IPT
GDNC
SPRD
CPN
NIC
PRICE
HEL
4,955.000
2
-
1lm Qbuz
R1
I+
-
Erredjvf
ESBP
-
YMMM+350
-
VHLQ+35
-
81.47000
Tranche Comments
7 lc: Comments: EXS2.1uk (juqsksu xhrh EXS1.8uk) 7oh kuk XTDF+350 as 99.75. Dwrrhn 0.50%. Zaww Fhrn 101 6h qrxs kaww;
Deal Comments
Ljgaq Pjup Luge Ptnp Ftpa
Use of Proceeds
Afgoh Mfip
Commentary
Upgrade Plan
Deal Flow
Upgrade Plan
B&I
BWICS & Inventory
This module is available on the Professional plan.
Learn more
Upgrade Plan
TRACE
This module is available on the Professional plan.
Learn more
Upgrade Plan
Research
Log In
Missing something? Tell us.